Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles L Daley

Showing results (221-230 of 230) with videos related to

Pageof 23
Sort By:
You have reached the last page of results.This site can display upto 230 results.
Chest|May 9, 2017
Pharmacotherapy for Non-Cystic Fibrosis Bronchiectasis: Results From an NTM Info & Research Patient Survey and the Bronchiectasis and NTM Research RegistryEmily Henkle, Timothy R Aksamit, Alan F Barker, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 13, 2016
Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible TuberculosisPayam Nahid, Susan E Dorman, Narges Alipanah, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 14, 2016
Executive Summary: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible TuberculosisPayam Nahid, Susan E Dorman, Narges Alipanah, et al.
American Journal of Respiratory and Critical Care Medicine|July 22, 2025
Updates on the Treatment of Drug-Susceptible and Drug-Resistant Tuberculosis: An Official ATS/CDC/ERS/IDSA Clinical Practice GuidelineJussi J Saukkonen, Raquel Duarte, Sonal S Munsiff, et al.
Cell|May 14, 2022
Host and pathogen response to bacteriophage engineered against Mycobacterium abscessus lung infectionJerry A Nick, Rebekah M Dedrick, Alice L Gray, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 13, 2025
Trial design of bacteriophage therapy for nontuberculous mycobacteria pulmonary disease in cystic fibrosis: The POSTSTAMP studyJerry A Nick, Stacey L Martiniano, Valerie K Lovell, et al.
American Journal of Respiratory and Critical Care Medicine|November 16, 2019
Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice GuidelinePayam Nahid, Sundari R Mase, Giovanni Battista Migliori, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 21, 2025
Accuracy of VIDAS® TB-IGRA in TB patients and individuals with different thresholds of exposureDelia Goletti, Niaz Banaei, Rahul Batra, et al.
Bulletin of the World Health Organization|July 29, 2024
Target regimen profiles for tuberculosis treatmentChristian Lienhardt, Kelly E Dooley, Payam Nahid, et al.
The European Respiratory Journal|April 20, 2013
The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative studyWouter Hoefsloot, Jakko van Ingen, Claire Andrejak, et al.
Pageof 23

Showing results (221-230 of 230) with videos related to

Sort By:
Pageof 23
You have reached the last page of results.This site can display upto 230 results.
Chest|May 9, 2017
Pharmacotherapy for Non-Cystic Fibrosis Bronchiectasis: Results From an NTM Info & Research Patient Survey and the Bronchiectasis and NTM Research RegistryEmily Henkle, Timothy R Aksamit, Alan F Barker, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 13, 2016
Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible TuberculosisPayam Nahid, Susan E Dorman, Narges Alipanah, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 14, 2016
Executive Summary: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible TuberculosisPayam Nahid, Susan E Dorman, Narges Alipanah, et al.
American Journal of Respiratory and Critical Care Medicine|July 22, 2025
Updates on the Treatment of Drug-Susceptible and Drug-Resistant Tuberculosis: An Official ATS/CDC/ERS/IDSA Clinical Practice GuidelineJussi J Saukkonen, Raquel Duarte, Sonal S Munsiff, et al.
Cell|May 14, 2022
Host and pathogen response to bacteriophage engineered against Mycobacterium abscessus lung infectionJerry A Nick, Rebekah M Dedrick, Alice L Gray, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 13, 2025
Trial design of bacteriophage therapy for nontuberculous mycobacteria pulmonary disease in cystic fibrosis: The POSTSTAMP studyJerry A Nick, Stacey L Martiniano, Valerie K Lovell, et al.
American Journal of Respiratory and Critical Care Medicine|November 16, 2019
Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice GuidelinePayam Nahid, Sundari R Mase, Giovanni Battista Migliori, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 21, 2025
Accuracy of VIDAS® TB-IGRA in TB patients and individuals with different thresholds of exposureDelia Goletti, Niaz Banaei, Rahul Batra, et al.
Bulletin of the World Health Organization|July 29, 2024
Target regimen profiles for tuberculosis treatmentChristian Lienhardt, Kelly E Dooley, Payam Nahid, et al.
The European Respiratory Journal|April 20, 2013
The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative studyWouter Hoefsloot, Jakko van Ingen, Claire Andrejak, et al.
Pageof 23